A Study to Learn How the Study Medicine Called [14C]PF-07054894 is Processed by the Body
Launched by PFIZER · May 28, 2025
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a medicine called PF-07054894 to understand how the body processes it. The researchers want to find out how quickly the medicine is absorbed, how it is broken down, and how it is eliminated from the body. This is important because it helps determine how safe and effective the medicine could be for future use.
To participate in this study, you need to be a healthy male between the ages of 18 and 65, with a body weight of at least 110 pounds and a body mass index (BMI) between 18 and 32. If you join, you will need to attend scheduled visits and follow the treatment plan, which includes some laboratory tests. Although the trial is not recruiting yet, it offers a chance to contribute to important medical research while ensuring your health and safety are monitored throughout the process.
Gender
MALE
Eligibility criteria
- • 1. Healthy male, aged 18 years to 65 years at screening.
- • 2. Body mass index (BMI) of about 18 to 32 kilogram per meter squared, and a total body weight greater than 50 kilograms (110 pounds).
- • 3. Willing and able to comply with all scheduled visits, treatment plan, laboratory tests, lifestyle considerations, and other study procedures.
About Pfizer
Pfizer Inc. is a global leader in biopharmaceutical innovation, dedicated to discovering, developing, and delivering advanced therapies that enhance patient outcomes across a wide range of medical conditions. With a rich history of scientific research and a commitment to quality, Pfizer focuses on areas such as oncology, immunology, cardiology, and rare diseases. The company leverages cutting-edge technology and collaborates with healthcare professionals, regulatory bodies, and academic institutions to conduct rigorous clinical trials that ensure the safety and efficacy of its products. Pfizer's mission is to bring breakthroughs that change patients' lives, exemplifying its commitment to health and wellness worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Groningen, , Netherlands
Patients applied
Trial Officials
Pfizer CT.gov Call Center
Study Director
Pfizer
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported